Table 1.
Control | Treated | ||||||
---|---|---|---|---|---|---|---|
Parameter | Function | Before | 1 hour Post‐Tx | 8 hours Post‐Tx | Before | 1 hour Post‐Tx | 8 Hours Post‐Tx |
TNF‐α | P | 0.11 | 0.08 | 0.12 | 0.05 | 5.84 | 0.16 |
IL‐1β | P | 0.14 | 0.11 | 0.14 | 0.09 | 0.14 | 0.20 |
IL‐10 | A | 0.12 | 0.17 | 0.14 | 0.10 | 0.51 | 0.11 |
TIMP‐1 | A | 1.86 | 1.11 | 2.09 | 0.71 | 7.54 | 1.93 |
TGF‐β1 | Both | 0.72 | 0.74 | 0.81 | 0.51 | 1.30 | 0.30 |
MMP 9 | P | 0.23 | 0.25 | 0.27 | 0.19 | 5.21 | 0.17 |
VEGFA | A | 1.13 | 1.56 | 0.81 | 1.36 | 2.28 | 0.59 |
FGF‐7 | A | 0.33 | 0.86 | 1.47 | 0.57 | 3.97 | 2.79 |
BAD | P | 0.57 | 0.55 | 0.64 | 0.47 | 1.20 | 0.73 |
BCL 2 | A | 1.32 | 1.27 | 1.47 | 3.23 | 3.86 | 1.59 |
TRX‐2 | A | 11.93 | 18.13 | 13.39 | 11.77 | 73.98 | 16.63 |
The function of an evaluated marker can be Pro‐Apoptotic (P), Anti‐Apoptotic (A) or both (B). All values are expressed as a ratio to reference value.